Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Neurology and Neuroscience Reports
Erschienen in: Current Neurology and Neuroscience Reports 10/2016

01.10.2016 | Behavior (H Kirshner, Section Editor)

Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson’s Disease

verfasst von: Adam Nassery, Christina A. Palmese, Harini Sarva, Mark Groves, Joan Miravite, Brian Harris Kopell

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Deep brain stimulation (DBS) is effective for Parkinson’s disease (PD), dystonia, and essential tremor (ET). While motor benefits are well documented, cognitive and psychiatric side effects from the subthalamic nucleus (STN) and globus pallidus interna (GPi) DBS for PD are increasingly recognized. Underlying disease, medications, microlesions, and post-surgical stimulation likely all contribute to non-motor symptoms (NMS).
Literatur
1.
2.
Fields JA, Tröster AI, Woods SP, Higginson CI, Wilkinson SB, et al. Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. J Neurol Neurosurg Psychiatry. 2003;74:305–11.CrossRefPubMedPubMedCentral
3.
Jahanshahi M, Torkamani M, Beigi M, Wilkinson L, Page D, Madeley L, et al. Pallidal stimulation for primary generalised dystonia: effect on cognition, mood and quality of life. J Neurol. 2014;261:164–73.CrossRefPubMed
4.•
Pinsker M, Amtage F, Berger M, Nikkhah G, van Elst LT. Psychiatric side-effects of bilateral deep brain stimulation for movement disorders. Acta Neurochir Suppl. 2013;117:47–51. Psychiatric post-operative assessment with an average follow-up exceeding 3 years, establishing depression as the most common psychiatric side-effect of DBS, irrespective of target (STN, GPi, VIM).PubMed
5.
Benarroch EE. Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation. Neurology. 2008;70:1991–5.CrossRefPubMed
6.
Eskow Jaunarajs KL, Angoa-Perez M, Kuhn DM, Bishop C. Potential mechanisms underlying anxiety and depression in Parkinson’s disease: consequences of l-DOPA treatment. Neurosci Biobehav Rev. 2011;35:556–64.CrossRefPubMed
7.
Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121–34.CrossRefPubMed
8.
Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23:183–9. quiz 313.CrossRefPubMed
9.
Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain. 2010;133:1111–27.CrossRefPubMed
10.
Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord. 2002;17:372–7.CrossRefPubMed
11.
Castelli L, Perozzo P, Zibetti M, Crivelli B, Morabito U, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol. 2006;55:136–44.CrossRefPubMed
12.
Schneider F, Habel U, Volkmann J, Regel S, Kornischka J, et al. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch Gen Psychiatry. 2003;60:296–302.CrossRefPubMed
13.
Witt K, Daniels C, Herzog J, Lorenz D, Volkmann J, et al. Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2006;18:397–401.CrossRefPubMed
14.
Chandran S, Krishnan S, Rao RM, Sarma SG, Sarma PS, et al. Gender influence on selection and outcome of deep brain stimulation for Parkinson’s disease. Ann Indian Acad Neurol. 2014;17:66–70.CrossRefPubMedPubMedCentral
15.
Kalteis K, Standhardt H, Kryspin-Exner I, Brücke T, Volc D, et al. Influence of bilateral STN-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson’s disease. J Neural Transm (Vienna). 2006;113:1191–206.CrossRef
16.
Mahgoub NA, Kotbi N. Acute depression and suicidal attempt following lowering the frequency of deep brain stimulation. J Neuropsychiatry Clin Neurosci. 2009;21:468.CrossRefPubMed
17.
Soulas T, Gurruchaga JM, Palfi S, Cesaro P, Nguyen JP, et al. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79:952–4.CrossRefPubMed
18.
Temel Y, Kessels A, Tan S, Topdag A, Boon P, et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 2006;12:265–72.CrossRefPubMed
19.
Pariwatcharakul P, Clough C, Shotbolt P, Morris R, Hulse N, et al. Pathological crying after subthalamic nucleus stimulation. Mov Disord. 2013;28:1348–9.CrossRefPubMed
20.
Okun MS, Wu SS, Foote KD, Bowers D, Gogna S, et al. Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease? Neurosurgery. 2011;69:357–60. discussion 360–1.CrossRefPubMedPubMedCentral
21.
Porat O, Cohen OS, Schwartz R, Hassin-Baer S. Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2009;21:398–405.CrossRefPubMed
22.
Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 1999;340:1476–80.CrossRefPubMed
23.•
Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, et al. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson’s disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2013;84:1113–8. Randomized controlled trial composed of two phases assessing suicidal ideation in combined DBS (STN and GPi) versus best medical therapy, followed by STN and GPi target comparison spanning 2 years. This study establishes the safety of DBS in PD regarding suicide risk.CrossRefPubMedPubMedCentral
24.
25.
26.
Higuchi MA, Tsuboi Y, Inoue T, Fukuyama K, Abe H, et al. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson’s disease. Neuromodulation. 2015;18:113–7.CrossRefPubMed
27.
Robert GH, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, et al. Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study. Neurology. 2014;83:1620–6.CrossRefPubMed
28.
Butterfield LC, Cimino CR, Oelke LE, Hauser RA, Sanchez-Ramos J, et al. The independent influence of apathy and depression on cognitive functioning in Parkinson’s disease. Neuropsychology. 2010;24:721–30.CrossRefPubMed
29.
Kirsch-Darrow L, Mikos A, Bowers D. Does deep brain stimulation induce apathy in Parkinson’s disease? Front Biosci. 2008;13:5316–22.PubMed
30.
Kirsch-Darrow L, Zahodne LB, Marsiske M, Okun MS, Foote KD, et al. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17:182–8.CrossRefPubMedPubMedCentral
31.
Funkiewiez A, Ardouin C, Cools R, Krack P, Fraix V, et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson’s disease. Mov Disord. 2006;21:1656–62.CrossRefPubMed
32.
Le Jeune F, Drapier D, Bourguignon A, Péron J, Mesbah H, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009;73:1746–51.CrossRefPubMed
33.
Nirenberg MJ. Dopamine agonist withdrawal syndrome: implications for patient care. Drugs Aging. 2013;30:587–92.CrossRefPubMed
34.
Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589–95.CrossRefPubMed
35.
Couto MI, Monteiro A, Oliveira A, Lunet N, Massano J. Depression and anxiety following deep brain stimulation in Parkinson’s disease: systematic review and meta-analysis. Acta Medica Port. 2014;27:372–82.CrossRef
36.•
Okun MS, Wu SS, Fayad S, Ward H, Bowers D, et al. Acute and chronic mood and apathy outcomes from a randomized study of unilateral STN and GPi DBS. PLoS One. 2014;9:e114140. Randomized controlled assessment of anxiety in PD patients undergoing unilateral or bilateral STN and unilateral or bilateral GPi. This study emphasized the important role that dopaminergic therapy weaning plays in patient anxiety state.CrossRefPubMedPubMedCentral
37.
Chang C, Li N, Wu Y, Geng N, Ge S, et al. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson’s disease patients: a controlled study. J Neuropsychiatry Clin Neurosci. 2012;24:316–25.CrossRefPubMed
38.
York MK, Dulay M, Macias A, Levin HS, Grossman R, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79:789–95.CrossRefPubMed
39.
Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease? J Neurol. 2006;253:1083–91.CrossRefPubMed
40.
Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry. 2008;65:255–63.CrossRefPubMed
41.
42.
Molinoff P. Neurotransmission and the central nervous system. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics. 2011; 12th edition: 389.
43.
Mandat TS, Hurwitz T, Honey CR. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir (Wien). 2006;148:895–7. discussion 898.CrossRef
44.
Ugurlu TT, Acar G, Karadag F, Acar F. Manic episode following deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: a case report. Turk Neurosurg. 2014;24:94–7.PubMed
45.
Raucher-Chene D, Charrel CL, de Maindreville AD, Limosin F. Manic episode with psychotic symptoms in a patient with Parkinson’s disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci. 2008;273:116–7.CrossRefPubMed
46.
Herzog J, Reiff J, Krack P, Witt K, Schrader B, et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson’s disease. Mov Disord. 2003;18:1382–4.CrossRefPubMed
47.
Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, et al. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a 4 year follow-up study. Parkinsonism Relat Disord. 2005;11:157–65.CrossRefPubMed
48.
Ulla M, Thobois S, Llorca PM, Derost P, Lemaire JJ, et al. Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson’s disease: clinical, anatomical and functional imaging study. J Neurol Neurosurg Psychiatry. 2011;82:607–14.CrossRefPubMed
49.
Lim SY, O’Sullivan SS, Kotschet K, Gallagher DA, Lacey C, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease. J Clin Neurosci. 2009;16:1148–52.CrossRefPubMed
50.
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, et al. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 2008;58:37–47.CrossRefPubMed
51.
Wu K, Politis M, Piccini P. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J. 2009;85:590–6.CrossRefPubMed
52.
Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson’s disease. Brain. 2011;134:36–49.CrossRefPubMed
53.
Rogers RD, Wielenberg B, Wojtecki L, Elben S, Campbell-Meiklejohn D, et al. Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson’s disease. Exp Neurol. 2011;231:181–9.CrossRefPubMed
54.
Amami P, Dekker I, Piacentini S, Ferré F, Romito LM, et al. Impulse control behaviours in patients with Parkinson’s disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up. J Neurol Neurosurg Psychiatry. 2015;86:562–4.CrossRefPubMed
55.
Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, et al. Subthalamic deep brain stimulation and impulse control in Parkinson’s disease. Eur J Neurol. 2009;16:493–7.CrossRefPubMed
56.
Shotbolt P, Moriarty J, Costello A, Jha A, David A, et al. Relationships between deep brain stimulation and impulse control disorders in Parkinson’s disease, with a literature review. Parkinsonism Relat Disord. 2012;18:10–6.CrossRefPubMed
57.
Merims D, Giladi N. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson’s disease. Parkinsonism Relat Disord. 2008;14:273–80.CrossRefPubMed
58.
O’Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs. 2009;23:157–70.CrossRefPubMed
59.
Witjas T, Baunez C, Henry JM, Delfini M, Regis J, et al. Addiction in Parkinson’s disease: impact of subthalamic nucleus deep brain stimulation. Mov Disord. 2005;20:1052–5.CrossRefPubMed
60.
Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, et al. Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours. Brain. 2012;135:1463–77.CrossRefPubMed
61.
Moum SJ, Price CC, Limotai N, Oyama G, Ward H, et al. Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS One. 2012;7:e29768.CrossRefPubMedPubMedCentral
62.
Percheron G, François C, Talbi B, Meder JF, Fenelon G, et al. The primate motor thalamus analysed with reference to subcortical afferent territories. Stereotact Funct Neurosurg. 1993;60:32–41.CrossRefPubMed
63.
Nauta WJ, Mehler WR. Projections of the lentiform nucleus in the monkey. Brain Res. 1966;1:3–42.CrossRefPubMed
64.
Miyawaki E, Perlmutter JS, Tröster AI, Videen TO, Koller WC. The behavioral complications of pallidal stimulation: a case report. Brain Cogn. 2000;42:417–34.CrossRefPubMed
65.
Roane DM, Yu M, Feinberg TE, Rogers JD. Hypersexuality after pallidal surgery in Parkinson disease. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:247–51.PubMed
66.
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75:1062–9.CrossRefPubMedPubMedCentral
67.
Ding W, Ding LJ, Li FF, Han Y, Mu L. Neurodegeneration and cognition in Parkinson’s disease: a review. Eur Rev Med Pharmacol Sci. 2015;19:2275–81.PubMed
68.
Broen M, Duits A, Visser-Vandewalle V, Temel Y, Winogrodzka A. Impulse control and related disorders in Parkinson’s disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord. 2011;17:413–7.CrossRefPubMed
69.
Aybek S, Gronchi-Perrin A, Berney A, Chiuvé SC, Villemure JG, et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson’s disease. Mov Disord. 2007;22:974–81.CrossRefPubMed
70.
Witt K, Granert O, Daniels C, Volkmann J, Falk D, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson’s disease: results from a randomized trial. Brain. 2013;136:2109–19.CrossRefPubMed
71.
Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of 10 years’ experience. Mov Disord. 2007;22:1722–8.CrossRefPubMed
72.
Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, et al. Deep brain stimulation and cognitive functions in Parkinson’s disease: a 3-year controlled study. Mov Disord. 2009;24:1621–8.CrossRefPubMed
73.
Fasano A, Romito LM, Daniele A, Piano C, Zinno M, et al. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain. 2010;133:2664–76.CrossRefPubMed
74.
Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain. 2000;123:2091–108.CrossRefPubMed
75.
Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66:1830–6.CrossRefPubMed
76.
Yamanaka T, Ishii F, Umemura A, Miyata M, Horiba M, et al. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson’s disease. Clin Neurol Neurosurg. 2012;114:347–51.CrossRefPubMed
77.
Smeding HM, Esselink RA, Schmand B, Koning-Haanstra M, Nijhuis I, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD—a comparison of neuropsychological effects. J Neurol. 2005;252:176–82.CrossRefPubMed
78.
Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, et al. Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17:189–93.CrossRefPubMed
79.
Kim HJ, Jeon BS, Paek SH, Lee KM, Kim JY, et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease. J Neurol. 2014;261:1090–6.CrossRefPubMed
80.
Ehlen F, Krugel LK, Vonberg I, Schoenecker T, Kühn AA, et al. Intact lexicon running slowly—prolonged response latencies in patients with subthalamic DBS and verbal fluency deficits. PLoS One. 2013;8:e79247.CrossRefPubMedPubMedCentral
81.
Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s Disease. J Neurol Neurosurg Psychiatry. 2011;82:754–60.CrossRefPubMed
82.
Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, et al. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. Eur J Neurol. 2012;19:1525–31.CrossRefPubMed
83.
De Gaspari D, Siri C, Di Gioia M, Antonini A, Isella V, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12:289–95.CrossRefPubMed
84.
Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, et al. Cognitive outcome and reliable change indices 2 years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011;17:321–7.CrossRefPubMedPubMedCentral
85.
Tröster AI, Woods SP, Fields JA, Hanisch C, Beatty WW, et al. Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson’s disease. Brain Cogn. 2002;50:207–17.CrossRefPubMed
86.
Lefaucheur R, Derrey S, Martinaud O, Wallon D, Chastan N, et al. Early verbal fluency decline after STN implantation: is it a cognitive microlesion effect? J Neurol Sci. 2012;321:96–9.CrossRefPubMed
87.
Heo JH, Lee KM, Paek SH, Kim MJ, Lee JY, et al. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J Neurol Sci. 2008;273:19–24.CrossRefPubMed
88.
Castelli L, Rizzi L, Zibetti M, Angrisano S, Lanotte M, et al. Neuropsychological changes 1-year after subthalamic DBS in PD patients: A prospective controlled study. Parkinsonism Relat Disord. 2010;16:115–8.CrossRefPubMed
89.
Castelli L, Lanotte M, Zibetti M, Caglio M, Rizzi L, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol. 2007;254:1238–43.CrossRefPubMed
90.
Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:834–9.CrossRefPubMedPubMedCentral
91.
Birn RM, Kenworthy L, Case L, Caravella R, Jones TB, et al. Neural systems supporting lexical search guided by letter and semantic category cues: a self-paced overt response fMRI study of verbal fluency. Neuroimage. 2010;49:1099–107.CrossRefPubMed
92.
Sjöberg RL, Lidman E, Häggström B, Hariz MI, Linder J, et al. Verbal fluency in patients receiving bilateral versus left-sided deep brain stimulation of the subthalamic nucleus for Parkinson’s disease. J Int Neuropsychol Soc. 2012;18:606–11.CrossRefPubMed
93.
Troster AI, Woods SP, Fields JA. Verbal fluency declines after pallidotomy: an interaction between task and lesion laterality. Appl Neuropsychol. 2003;10:69–75.CrossRefPubMed
94.
Zahodne LB, Bowers D, Price CC, Bauer RM, Nisenzon A, et al. The case for testing memory with both stories and word lists prior to DBS surgery for Parkinson’s Disease. Clin Neuropsychol. 2011;25:348–58.CrossRefPubMedPubMedCentral
95.
Mikos A, Zahodne L, Okun MS, Foote K, Bowers D. Cognitive declines after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using Reliable Change, part II. Clin Neuropsychol. 2010;24:235–45.CrossRefPubMed
96.•
Yágüez L, Costello A, Moriarty J, Hulse N, Selway R, et al. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease. J Clin Neurosci. 2014;21:445–50. Prospective study assessing post-operative cognitive changes in patients with normal cognition and those with mild cognitive impairment (MCI), revealing that approximately 20% of those without initial cognitive impairment qualified as impaired by displaying significant memory deficits when tested 9 months post-operatively.CrossRefPubMed
97.
Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, et al. Parkinson’s disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain. 2011;134:2074–84.CrossRefPubMed
98.
Schüpbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68:267–71.CrossRefPubMed
99.•
Rothlind JC, York MK, Carlson K, Luo P, Marks Jr WJ, et al. Neuropsychological changes following deep brain stimulation surgery for Parkinson’s disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015;86:622–9. A 6 month prospective, randomized-controlled neurocognitive study comparing bilateral STN and GPi DBS with a best medical therapy treatment arm, documenting significant detriments in working memory and processing speed in a combined DBS group.CrossRefPubMed
100.
Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65:586–95.CrossRefPubMedPubMedCentral
Metadaten
Titel
Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson’s Disease
verfasst von
Adam Nassery
Christina A. Palmese
Harini Sarva
Mark Groves
Joan Miravite
Brian Harris Kopell
Publikationsdatum
01.10.2016
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 10/2016
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-016-0690-1

Weitere Artikel der Ausgabe 10/2016

Current Neurology and Neuroscience Reports 10/2016 Zur Ausgabe

Neuro-Ophthalmology (A Kawasaki, Section Editor)

Visual Cortex Plasticity Following Peripheral Damage To The Visual System: fMRI Evidence

Epilepsy (CW Bazil, Section Editor)

Recent Advances in Neonatal Seizures

Neuroimaging (DJ Brooks, Section Editor)

Connectivity Changes in Parkinson’s Disease

Demyelinating Disorders (DN Bourdette and M Cameron, Section Editors)

Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space

Dementia (KS Marder, Section Editor)

The Impact of Dementia on Family Caregivers: What Is Research Teaching Us?

Genetics (V Bonifati, Section Editor)

Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise